Jeffrey M. Spraggins

Jeffrey M. Spraggins

Auto-generated profile, based on publicly available information

Jeffrey M. Spraggins

Vanderbilt University

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 October 2019 in Nature
Verified
Journal Article
Open access
PDF file
HCHuBMAP Consortium
HuBMAP Consortium
WGWriting Group
Writing Group
MSMichael P Snyder
Michael P Snyder
SLShin Lin
Shin Lin
APAmanda Posgai
Amanda Posgai
JAJames Anderson
James Anderson
Transformative technologies are enabling the construction of three-dimensional maps of tissues with unprecedented spatial and molecular resolution. Over the next seven years, the NIH Common Fund Human Biomolecular Atlas Program (HuBMAP) intends to develop a widely accessible framework for comprehensively mapping the human body at single-cell resolution by supporting technology development, data acquisition, and detailed spatial mapping. HuBMAP will integrate its efforts with other funding agencies, programs, consortia, and the biomedical research community at large towards the shared vision of a comprehensive, accessible three-dimensional molecular and cellular atlas of the human body, in health and under various disease conditions.

26 September 2011 in Chemical Reviews
Verified
Journal Article
Closed access
KBKarin A. Zemski Berry
Karin A. Zemski Berry
JHJoseph A. Hankin
Joseph A. Hankin
RBRobert M. Barkley
Robert M. Barkley
JSJeffrey M. Spraggins
Jeffrey M. Spraggins
RCRichard M. Caprioli
Richard M. Caprioli
RMRobert Murphy
Robert Murphy

22 November 2021 in Nature Methods
Verified
Journal Article
Closed access
PDF file
JHJohn W. Hickey
John W. Hickey
Elizabeth Kathleen NeumannElizabeth Kathleen Neumann
Elizabeth Kathleen Neumann
ARAndrea J. Radtke
Andrea J. Radtke
JCJeannie M. Camarillo
Jeannie M. Camarillo
RBRebecca T. Beuschel
Rebecca T. Beuschel
SSSinem K. Saka
Sinem K. Saka

3 June 2020 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
TMTeresa Manzo
Teresa Manzo
BPBoone Prentice
Boone Prentice
KAKristin G. Anderson
Kristin G. Anderson
ARAyush Raman
Ayush Raman
ASAislyn Schalck
Aislyn Schalck
LNLuigi Nezi
Luigi Nezi
CD8+ T cells are master effectors of antitumor immunity, and their presence at tumor sites correlates with favorable outcomes. However, metabolic constraints imposed by the tumor microenvironment (TME) can dampen their ability to control tumor progression. We describe lipid accumulation in the TME areas of pancreatic ductal adenocarcinoma (PDA) populated by CD8+ T cells infiltrating both murine and human tumors. In this lipid-rich but otherwise nutrient-poor TME, access to using lipid metabolism becomes particularly valuable for sustaining cell functions. Here, we found that intrapancreatic CD8+ T cells progressively accumulate specific long-chain fatty acids (LCFAs), which, rather than provide a fuel source, impair their mitochondrial function and trigger major transcriptional reprogramming of pathways involved in lipid metabolism, with the subsequent reduction of fatty acid catabolism. In particular, intrapancreatic CD8+ T cells specifically exhibit down-regulation of the very-long-chain acyl-CoA dehydrogenase (VLCAD) enzyme, which exacerbates accumulation of LCFAs and very-long-chain fatty acids (VLCFAs) that mediate lipotoxicity. Metabolic reprogramming of tumor-specific T cells through enforced expression of ACADVL enabled enhanced intratumoral T cell survival and persistence in an engineered mouse model of PDA, overcoming one of the major hurdles to immunotherapy for PDA.

23 February 2015 in Nature Methods
Verified
Journal Article
Open access
PDF file
RPRaf Van de Plas
Raf Van de Plas
JYJunhai Yang
Junhai Yang
JSJeffrey Spraggins
Jeffrey Spraggins
RCRichard M Caprioli
Richard M Caprioli
An approach to fuse images from imaging mass spectrometry and microscopy provides biological insights into molecular tissue distributions beyond what can be obtained from either modality individually. We describe a predictive imaging modality created by 'fusing' two distinct technologies: imaging mass spectrometry (IMS) and microscopy. IMS-generated molecular maps, rich in chemical information but having coarse spatial resolution, are combined with optical microscopy maps, which have relatively low chemical specificity but high spatial information. The resulting images combine the advantages of both technologies, enabling prediction of a molecular distribution both at high spatial resolution and with high chemical specificity. Multivariate regression is used to model variables in one technology, using variables from the other technology. We demonstrate the potential of image fusion through several applications: (i) 'sharpening' of IMS images, which uses microscopy measurements to predict ion distributions at a spatial resolution that exceeds that of measured ion images by ten times or more; (ii) prediction of ion distributions in tissue areas that were not measured by IMS; and (iii) enrichment of biological signals and attenuation of instrumental artifacts, revealing insights not easily extracted from either microscopy or IMS individually.

8 October 2019 in Analytical Chemistry
Verified
Journal Article
Closed access
JSJeffrey M. Spraggins
Jeffrey M. Spraggins
KDKaterina V. Djambazova
Katerina V. Djambazova
EREmilio S. Rivera
Emilio S. Rivera
LMLukasz G. Migas
Lukasz G. Migas
Elizabeth Kathleen NeumannElizabeth Kathleen Neumann
Elizabeth Kathleen Neumann
RCRichard M. Caprioli
Richard M. Caprioli